Literature DB >> 11368926

Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia.

A M Oltra1, F Carbonell, C Tormos, A Iradi, G T Sáez.   

Abstract

Chronic lymphocytic leukemia (CLL) is a neoplastic disease susceptible to antioxidant enzyme alterations and oxidative stress. We have examined the activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), and the oxidized/reduced glutathione (GSSG/GSH) ratio together with the levels of malondialdehyde (MDA) and 8-oxo-2'-deoxyguanosine (8-oxo-dG) in lymphocytes of CLL patients and compared them with those of normal subjects of the same age. SOD and CAT activity decreased in CLL lymphocytes while GPx activity increased. GSH content of CLL lymphocytes also increased, and GSSG concentration remained constant. Thus, a reduced GSSG/GSH ratio was obtained. The oxidation product MDA, and the damaged DNA base 8-oxo-dG were also increased in CLL. The observed changes in enzyme activities, GSSG/GSH ratio, and MDA were significantly enhanced as the duration of the disease increased in years. The results support a predominant oxidative stress status in CLL lymphocytes and emphasize the role of the examined parameters as markers of the disease evolution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368926     DOI: 10.1016/s0891-5849(01)00521-4

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  40 in total

1.  Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.

Authors:  Sabyasachi Biswas; Xiaobin Zhao; Andrew P Mone; Xiaokui Mo; Melissa Vargo; David Jarjoura; John C Byrd; Natarajan Muthusamy
Journal:  Leuk Res       Date:  2010-02-19       Impact factor: 3.156

2.  Oxidative stress and recurrent aphthous stomatitis.

Authors:  Jose Bagan; Guillermo Saez; Carmen Tormos; Carmen Gavalda; Jose M Sanchis; Leticia Bagan; Crispian Scully
Journal:  Clin Oral Investig       Date:  2014-01-10       Impact factor: 3.573

3.  The 1-carbamoyl-2-oxo-4,5-dihydroxyimidazolidine component of ROS-induced DNA damage in white blood cells.

Authors:  Herbert Iijima; Helen B Patrzyc; Edwin E Budzinski; Jean B Dawidzik; Harold G Freund; Harold C Box
Journal:  Radiat Res       Date:  2010-07       Impact factor: 2.841

4.  Involvement of oxidative stress in the relapse of acute myeloid leukemia.

Authors:  Fu-Ling Zhou; Wang-Gang Zhang; Yong-Chang Wei; Shan Meng; Gai-Gai Bai; Bai-Yan Wang; Hui-Yun Yang; Wei Tian; Xin Meng; Hui Zhang; She-Ping Chen
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

5.  Pyrimidine base damage is increased in women with BRCA mutations.

Authors:  Edwin E Budzinski; Helen B Patrzyc; Jean B Dawidzik; Harold G Freund; Peter Frederick; Heidi E Godoy; Nicoleta C Voian; Kunle Odunsi; Harold C Box
Journal:  Cancer Lett       Date:  2013-04-11       Impact factor: 8.679

Review 6.  xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Authors:  Jinyun Liu; Xiaojun Xia; Peng Huang
Journal:  Mol Ther       Date:  2020-09-02       Impact factor: 11.454

Review 7.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

8.  Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.

Authors:  Dunyaporn Trachootham; Hui Zhang; Wan Zhang; Li Feng; Min Du; Yan Zhou; Zhao Chen; Helene Pelicano; William Plunkett; William G Wierda; Michael J Keating; Peng Huang
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

9.  Profiling oxidative DNA damage: effects of antioxidants.

Authors:  Harold C Box; Helen B Patrzyc; Edwin E Budzinski; Jean B Dawidzik; Harold G Freund; Nathalie C Zeitouni; Martin C Mahoney
Journal:  Cancer Sci       Date:  2012-09-18       Impact factor: 6.716

10.  A study of pyrimidine base damage in relation to oxidative stress and cancer.

Authors:  H Iijima; H B Patrzyc; E E Budzinski; H G Freund; J B Dawidzik; K J Rodabaugh; H C Box
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.